Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(10%)
Results Posted
20%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
2
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting110%
terminated110%
unknown330%
completed550%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10